,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
  • Forum
———Top menu
Login
 

GLOBALE DERMATOLOGIE

Globale DermatologieGlobale Dermatologie
Globale Dermatologie
Portail d'information sur la dermatologie

GLOBALE DERMATOLOGIE

  • Home
  • About
  • General informations
  • For professionnels
  • Posts in other languages
    • Allemand (Deutsch)
    • arabe (العربية)
    • chinois (中文)
    • espagnol (Español)
    • italien (Italiano)
    • japonais (日本語)
    • portugais (Português)
    • russe (русский язык)
    • tagalog
  • Find a dermatologist
  • Register
  • Contact
Menu back  
  • Home
  • About
  • General informations
  • For professionnels
  • Posts in other languages
    • back
    • Allemand (Deutsch)
    • arabe (العربية)
    • chinois (中文)
    • espagnol (Español)
    • italien (Italiano)
    • japonais (日本語)
    • portugais (Português)
    • russe (русский язык)
    • tagalog
  • Find a dermatologist
  • Register
  • Contact
 

Daily Archives: Sunday July 27th, 2014

You are here:
  1. Home
  2. 2014
  3. July
  4. 27

Secukinumab: A Biologic To Treat Psoriasis

Il-17 targeting is the new trend in the biologic systemic treatment of psoriasis. Ustekinumab (Stelara) is the main one used today in that sense. Secukinumab: is a fully anti-interleukin-17A monoclonal antibody is (at the time of publishing this article) the latest Il-17A drug to have exited phase III trials. The results out of two studies…

Sunday July 27th, 2014ArticlesBy ofredon@oxicat.com
© Globale Dermatologie 2015 - Tous droits réservés